GB9824091D0 - Biological materials and methods useful in the diagnosis and treatment of diseases - Google Patents
Biological materials and methods useful in the diagnosis and treatment of diseasesInfo
- Publication number
- GB9824091D0 GB9824091D0 GBGB9824091.4A GB9824091A GB9824091D0 GB 9824091 D0 GB9824091 D0 GB 9824091D0 GB 9824091 A GB9824091 A GB 9824091A GB 9824091 D0 GB9824091 D0 GB 9824091D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- diagnosis
- diseases
- treatment
- biological materials
- methods useful
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (20)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9824091.4A GB9824091D0 (en) | 1998-11-04 | 1998-11-04 | Biological materials and methods useful in the diagnosis and treatment of diseases |
GB9925804A GB2348203B (en) | 1998-11-04 | 1999-11-01 | Solube beta-forms of prion proteins, methods of preparation and use |
GB0113011A GB2362385B (en) | 1998-11-04 | 1999-11-01 | Non-aggregated ß-forms of prion proteins |
GB0205963A GB2371049B (en) | 1998-11-04 | 1999-11-01 | Methods of making antibodies against ß-forms of prion proteins and their uses |
EP99952693A EP1127069B1 (en) | 1998-11-04 | 1999-11-02 | Method of making a monomeric beta-form of a prion protein |
PCT/GB1999/003617 WO2000026238A2 (en) | 1998-11-04 | 1999-11-02 | Biological materials and methods useful in the diagnosis and treatment of prion diseases |
BR9915084-0A BR9915084A (en) | 1998-11-04 | 1999-11-02 | Methods of producing a beta form of a prion protein, an antibody and a prion protein aggregate, of obtaining a non-aggregated concrete form of a prion protein and a binding agent, of detecting the presence of a non-aggregate in a biological sample. fibrillar and a prion protein, antibodies and a beta form of prion protein or its aggregate in a sample, to identify a substance, to prevent and / or treat a deprived disease, to diagnose a predisposition for the presence of a prion disease and detract from a biological sample, beta form of a prion protein, antibody, hybridoma cell, agent, non-fibrillary aggregate, uses of a binding agent, an aggregate and beta form of a prion protein, kit to diagnose a disease of primary, pharmaceutical composition and vaccine composition |
NZ511426A NZ511426A (en) | 1998-11-04 | 1999-11-02 | Biological materials and methods useful in the diagnosis and treatment of diseases |
AT99952693T ATE493435T1 (en) | 1998-11-04 | 1999-11-02 | METHOD FOR PRODUCING THE MONOMERIC BETA FORM OF A PRION PROTEIN |
DE69943091T DE69943091D1 (en) | 1998-11-04 | 1999-11-02 | METHOD FOR PRODUCING THE MONOMERIC BETA FORM OF A PRION PROTEIN |
AU64807/99A AU773763B2 (en) | 1998-11-04 | 1999-11-02 | Biological materials and methods useful in the diagnosis and treatment of diseases |
US09/431,887 US6534036B1 (en) | 1998-11-04 | 1999-11-02 | Biological materials and methods useful in the diagnosis and treatment of diseases |
JP2000579625A JP2002531065A (en) | 1998-11-04 | 1999-11-02 | Biological materials and methods useful in diagnosis and treatment of disease |
CA002348751A CA2348751A1 (en) | 1998-11-04 | 1999-11-02 | Biological materials and methods useful in the diagnosis and treatment of diseases |
ARP990105585A AR035004A1 (en) | 1998-11-04 | 1999-11-04 | A BETA FORM OF PRION PROTEIN, A METHOD FOR THEIR PREPARATION, A COMPOSITION THAT CONTAINS IT, USE OF THE SAME FOR THE MANUFACTURE OF A COMPOSITION, A MONOCLONAL ANTIBODY, A METHOD FOR THEIR PREPARATION, A HYBRIDOMA CELL, A LINK AGENT OF THE BETA FORM, A METHOD FOR YOUR PREPA |
ZA200103947A ZA200103947B (en) | 1998-11-04 | 2001-05-15 | Biological materials and methods useful in the diagnosis and treatment of diseases. |
US10/304,630 US20030161836A1 (en) | 1998-11-04 | 2002-11-26 | Biological materials and methods useful in the diagnosis and treatment of diseases |
ZA200301143A ZA200301143B (en) | 1998-11-04 | 2003-02-10 | Biological materials and methods useful in the diagnosis and treatment of diseases. |
US11/140,416 US7875259B2 (en) | 1998-11-04 | 2005-05-27 | Biological materials and methods useful in the diagnosis and treatment of diseases |
US11/974,794 US20080241861A1 (en) | 1998-11-04 | 2007-10-16 | Biological materials and methods useful in the diagnosis and treatment of diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9824091.4A GB9824091D0 (en) | 1998-11-04 | 1998-11-04 | Biological materials and methods useful in the diagnosis and treatment of diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9824091D0 true GB9824091D0 (en) | 1998-12-30 |
Family
ID=10841787
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9824091.4A Ceased GB9824091D0 (en) | 1998-11-04 | 1998-11-04 | Biological materials and methods useful in the diagnosis and treatment of diseases |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB9824091D0 (en) |
ZA (2) | ZA200103947B (en) |
-
1998
- 1998-11-04 GB GBGB9824091.4A patent/GB9824091D0/en not_active Ceased
-
2001
- 2001-05-15 ZA ZA200103947A patent/ZA200103947B/en unknown
-
2003
- 2003-02-10 ZA ZA200301143A patent/ZA200301143B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200103947B (en) | 2003-02-17 |
ZA200301143B (en) | 2003-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9925804D0 (en) | Biological materials and method useful in the diagnosis and treatment of diseases | |
ATE349428T1 (en) | PROSTAGLAND INAGONISTS AND THEIR USE IN THE TREATMENT OF BONE DISEASES | |
IL205242A0 (en) | Substituted oxazolidinones and their use in the field of blood coagulation | |
PT1083889E (en) | TETRA-HYDROFOLANTALINE COMPOUNDS AND ITS USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | |
EP0963219A4 (en) | Manipulations of nitrosative and oxidatives stress in the treatment of disease | |
DE69805438D1 (en) | MIXING AND CHARGING OPENING FOR MEDICAL TREATMENT | |
EP1129217A4 (en) | Compositions and methods of disease diagnosis and therapy | |
IL128894A0 (en) | Materials and methods relating to the diagnosis and treatment of diabetes and obesity | |
AP2001002102A0 (en) | Pharmaceutical agents for the treatment of parkinson's disease and adhd and microadenomas | |
GB0019302D0 (en) | Biological materials and the use thereof for the treatment of disease | |
AU6502199A (en) | Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer | |
GB9419553D0 (en) | Polypeptides and their use in the treatment of auto-immune disease | |
NO20020207L (en) | Biological materials and methods useful in the diagnosis and treatment of disease | |
DE69636367D1 (en) | T-PA POLYMORPHISM AND ITS USE IN THE RISK DIAGNOSIS OF THROMBUS ASSOCIATED DISEASES | |
AU2001253886A1 (en) | Methylxanthines in the diagnosis and treatment of autistic disorder | |
AU2001296477A1 (en) | Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas | |
GB9509461D0 (en) | DNA molecules and constructs and their use in the treatment of mastitis | |
GB0113011D0 (en) | Biological materials and methods useful in the diagnosis and treatment of diseases | |
GB9824091D0 (en) | Biological materials and methods useful in the diagnosis and treatment of diseases | |
GB0205963D0 (en) | Biological materials and methods useful in the diagnosis and treatment of diseases | |
GB9908059D0 (en) | Diagnosis and treatment of diseases | |
GB9917878D0 (en) | Biological materials and methods useful in the diagnosis and treatment of diseases | |
GB9906217D0 (en) | Biological materials and methods useful in the diagnosis and treatment of diseases | |
EP1023076A4 (en) | Use of the p-ten suppressor gene in diagnosis and treatment of cancer | |
GB9917491D0 (en) | Biological materials and methods useful in the diagnosis and treastment of diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |